Effects of epidermal growth factor on maternal and fetal serum amino acid levels in rats.
Pregnant rats were subcutaneously administered with mouse epidermal growth factor (EGF) at the concentration of 0, 100, or 200 micrograms/kg body weight/day from day 18 to 21 of gestation. The amino acid analysis by high-performance liquid chromatography demonstrated that the umbilical venous/maternal and fetal/maternal ratio of serum proline concentration increased in EGF dose-dependent manner accompanied by the increase in the ratios of total fetal weight and placental weight to maternal body weight gain. These results suggested that EGF regulates fetal growth by, as one of its possible mechanism, promoting placental proline supply from mother to fetus.
Bonkobara
M
M
Department of Veterinary Clinical Pathobiology, Graduate School of Agricultural and Life Sciences, University of Tokyo, Japan.
Boonrit
T
T
Onda
K
K
Matsuki
N
N
Inaba
M
M
Ono
K
K
D000596:Amino Acids / Q000097:blood*; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005312:Fetal Blood / Q000187:drug effects / Q000378:metabolism*; D005333:Fetus / Q000187:drug effects / Q000502:physiology; D007279:Injections, Subcutaneous; D008431:Maternal-Fetal Exchange; D051379:Mice; D011247:Pregnancy; D011392:Proline / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D014471:Umbilical Veins; D015430:Weight Gain
D000596:Amino Acids; D004815:Epidermal Growth Factor; D011392:Proline